Prelude Capital Management’s LENZ Therapeutics LENZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-4,083
| Closed | -$74.9K | – | 1445 |
|
|
2023
Q4 | $74.9K | Sell |
4,083
-43
| -1% | -$789 | 0.01% | 919 |
|
|
2023
Q3 | $71.6K | Sell |
4,126
-1,665
| -29% | -$28.9K | ﹤0.01% | 875 |
|
|
2023
Q2 | $105K | Buy |
5,791
+1,205
| +26% | +$21.9K | 0.01% | 809 |
|
|
2023
Q1 | $78.6K | Sell |
4,586
-300
| -6% | -$5.15K | ﹤0.01% | 878 |
|
|
2022
Q4 | $114K | Buy |
4,886
+186
| +4% | +$4.32K | 0.01% | 921 |
|
|
2022
Q3 | $104K | Buy |
4,700
+1,206
| +35% | +$26.7K | ﹤0.01% | 1126 |
|
|
2022
Q2 | $67K | Buy |
+3,494
| New | +$67K | ﹤0.01% | 1246 |
|